Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

17.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Process Analytical Technology-Integrated FT-IR and Raman Spectroscopies for Efficient Reactive Liquid-Liquid Extraction Processing in Lithium Recycling.

ACS omega·2025
Same author

Digital Twin for the Production of hMSC-Derived Extracellular Vesicles for Applications in Cell and Gene Therapy toward Autonomous Operation.

ACS omega·2025
Same author

Advanced Freeze-Drying Modeling: Validation of a Sorption-Sublimation Model.

ACS omega·2025
Same author

Platform Process for an Autonomous Production of Virus-like Particles.

ACS omega·2025
Same author

Digital Twin for Continuous Production of Virus-like Particles toward Autonomous Operation.

ACS omega·2024
Same author

Pressurized Hot Water Extraction as Green Technology for Natural Products as Key Technology with Regard to Hydrodistillation and Solid-Liquid Extraction.

ACS omega·2024

Related Experiment Video

Updated: Feb 22, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.4K

Trends in Upstream and Downstream Process Development for Antibody Manufacturing.

Petra Gronemeyer1, Reinhard Ditz2, Jochen Strube3

  • 1Institute for Separation and Process Technology, Clausthal University of Technology, Leibnizstraße 15, D-38678 Clausthal-Zellerfeld, Germany. gronemeyer@itv.tu-clausthal.de.

Bioengineering (Basel, Switzerland)
|September 29, 2017
PubMed
Summary

Increasing antibody titers and impurity complexity challenge bioprocess development. New strategies are needed to optimize downstream processing and reduce work-up costs for efficient antibody production.

Keywords:
downstream processinghost cell proteinsprocess developmentprocess integrationupstream processing

More Related Videos

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.9K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.4K

Related Experiment Videos

Last Updated: Feb 22, 2026

Laboratory Scale Production and Purification of a Therapeutic Antibody
09:54

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

18.4K
Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
07:53

Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study

Published on: August 16, 2019

9.9K
Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

15.4K

Area of Science:

  • Biotechnology
  • Biopharmaceutical Manufacturing
  • Process Engineering

Background:

  • Rising product titers in antibody production increase impurity levels and process complexity.
  • Higher product quality demands necessitate advanced analytics and increase work-up costs.
  • Impurity concentration and composition vary significantly with culture conditions, impacting downstream strategy.

Purpose of the Study:

  • To review current methods for optimizing antibody production processes.
  • To identify challenges in downstream processing due to evolving production demands.
  • To explore new approaches for process integration and development.

Main Methods:

  • Review of existing literature on bioprocess optimization and impurity profiling.
  • Analysis of the impact of culture conditions on impurity profiles.
  • Assessment of current and alternative separation technologies for downstream processing.

Main Results:

  • Product titers and impurity profiles are increasingly complex, posing challenges for downstream processing.
  • Impurity variations significantly influence work-up strategies and associated costs.
  • Existing unit operations require adaptation, and novel separation technologies are needed.

Conclusions:

  • Downstream processing bottlenecks necessitate innovative solutions for antibody manufacturing.
  • Optimization of existing methods and exploration of new technologies are crucial for efficient bioprocess development.
  • Addressing impurity challenges is key to managing costs and ensuring product quality.